Details of the Drug | DrugMAP

General Information of Drug (ID: DMULDGG)

Drug Name

ONO-6950

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C36H37F2NO5
Canonical SMILES: CC1=C(C=CC=C1F)CCCCOC2=CC=C(C=C2)C#CC3=C4C(=C(C=C3)F)C(=C(N4CCCC(=O)O)C)CCCC(=O)O
InChI: 1S/C36H37F2NO5/c1-24-27(9-5-11-31(24)37)8-3-4-23-44-29-19-15-26(16-20-29)14-17-28-18-21-32(38)35-30(10-6-12-33(40)41)25(2)39(36(28)35)22-7-13-34(42)43/h5,9,11,15-16,18-21H,3-4,6-8,10,12-13,22-23H2,1-2H3,(H,40,41)(H,42,43)
InChIKey: SILHYVDKGHXGBL-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 46830962
CAS Number: 1232861-58-3
TTD ID: D0U5YM

References

1	ClinicalTrials.gov (NCT01551147) A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma. U.S. National Institutes of Health.